QuickView for YDL103C;jsessionid=15F15BB478DC6C77651BC16CE76A6F8A;jsessionid=FA09DD4A5D65571BA1AD979499E356E2;jsessionid=5DB5107377C50D220B2B02849FAC3A0E;jsessionid=161EA4FB6A70DC430F4519468CC7F620;jsessionid=696890CAB45EBF2E3C87D2130F1D510F;jsessionid=04DD7945FFF6B66F9A7BC14DACB3FACA;jsessionid=F82D40F180CFDEF128569B3CAA71F3D6;jsessionid=7DA135EEF7EBCCBAD447BA62D1FBAEB4;jsessionid=BEDA3E990C4508D7F9722A0521BD6EBE (gene)

1. Cyst fluid glycoproteins accurately distinguishing malignancies of pancreatic cystic neoplasm.
2. Clinical Evaluation of Cystic Renal Masses With Bosniak Classification by Contrast-Enhanced Ultrasou…
3. Feasibility of Surveillance for Mucinous Cystic Neoplasm of the Pancreas: A Multi-Institutional Retr…
4. Clinicopathological and genetic characteristics of congenital cystic adenomatoid malformation of lun…
5. The added value of contrast-enhanced ultrasound in evaluation of indeterminate small solid renal mas…

There were no clinical trials for YDL103C;jsessionid=15F15BB478DC6C77651BC16CE76A6F8A;jsessionid=FA09DD4A5D65571BA1AD979499E356E2;jsessionid=5DB5107377C50D220B2B02849FAC3A0E;jsessionid=161EA4FB6A70DC430F4519468CC7F620;jsessionid=696890CAB45EBF2E3C87D2130F1D510F;jsessionid=04DD7945FFF6B66F9A7BC14DACB3FACA;jsessionid=F82D40F180CFDEF128569B3CAA71F3D6;jsessionid=7DA135EEF7EBCCBAD447BA62D1FBAEB4;jsessionid=BEDA3E990C4508D7F9722A0521BD6EBE